Particles and Prejudice: Nanomedicine Approaches to Reducing Health Disparities in Endometrial Cancer

Claire E. Rowlands, Abigail M. Folberg, Zachary K. Beickman, Eric J. Devor, Kimberly K. Leslie, Brittany E. Givens

Research output: Contribution to journalReview articlepeer-review


Endometrial cancer is the most common gynecological malignancy worldwide and unfortunately has a much higher mortality rate in Black women compared with White women. Many potential factors contribute to these mortality rates, including the underlying effects of systemic and interpersonal racism. Furthermore, other trends in medicine have potential links to these rates including participation in clinical trials, hormone therapy, and pre-existing health conditions. Addressing the high incidence and disparate mortality rates in endometrial cancer requires novel methods, such as nanoparticle-based therapeutics. These therapeutics have been growing in increasing prevalence in pre-clinical development and have far-reaching implications in cancer therapy. The rigor of pre-clinical studies is enhanced by the likeness of the model to the human body. In systems for 3D cell culture, for example, the extracellular matrix mimics the tumor more closely. The increasing emphasis on precision medicine can be applied to cancer using nanoparticle-based methods and applied to pre-clinical models by using patient-derived model data. This review highlights the intersections of nanomedicine, precision medicine, and racial disparities within endometrial cancer and provides insights into reducing health disparities using recent scientific advances on the nanoscale.

Original languageEnglish
StateAccepted/In press - 2023

Bibliographical note

Funding Information:
B.E.G. acknowledges support from the University of Kentucky Clinical and Translational Sciences funded by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998. K.K.L. acknowledges support from the NIH National Cancer Institute through grant number 2R01CA 99908‐16A1, and through the U.S. Department of Defense grant numbers OC190352 and CA210610. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the DoD.

Publisher Copyright:
© 2023 Wiley-VCH GmbH.


  • chemotherapeutics
  • endometrial cancer
  • health disparities
  • nanoparticles
  • racial bias

ASJC Scopus subject areas

  • Biotechnology
  • Chemistry (all)
  • Biomaterials
  • Materials Science (all)
  • Engineering (miscellaneous)


Dive into the research topics of 'Particles and Prejudice: Nanomedicine Approaches to Reducing Health Disparities in Endometrial Cancer'. Together they form a unique fingerprint.

Cite this